Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Karlowsky

Showing results (31-40 of 76) with videos related to

Pageof 8
Sort By:
Journal of Clinical Microbiology|July 17, 1998
Screening of stool samples for identification of vancomycin-resistant Enterococcus isolates should include the methyl-alpha-D-glucopyranoside test to differentiate nonmotile Enterococcus gallinarum from E. faeciumC Y Turenne, D J Hoban, J A Karlowsky, et al.
Diagnostic Microbiology and Infectious Disease|November 14, 1997
Candidemia in a Canadian tertiary care hospital from 1976 to 1996J A Karlowsky, G G Zhanel, K A Klym, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Influence of human serum on pharmacodynamic properties of an investigational glycopeptide, LY333328, and comparator agents against Staphylococcus aureusG G Zhanel, I D Kirkpatrick, D J Hoban, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1993
In vitro postantibiotic effects following multiple exposures of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli in pooled human cerebrospinal fluid and Mueller-Hinton brothJ A Karlowsky, G G Zhanel, R J Davidson, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2009
In vitro activity of colistin (polymyxin E) against 3,480 isolates of gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD study, 2007-2008A Walkty, M DeCorby, K Nichol, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1996
In vitro characterization of aminoglycoside adaptive resistance in Pseudomonas aeruginosaJ A Karlowsky, M H Saunders, G A Harding, et al.
Diagnostic Microbiology and Infectious Disease|October 9, 2014
In vitro activity of oritavancin against Gram-positive pathogens isolated in Canadian hospital laboratories from 2011 to 2013J A Karlowsky, A J Walkty, M R Baxter, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Susceptibilities of Candida species isolated from the lower gastrointestinal tracts of high-risk patients to the new semisynthetic echinocandin LY303366 and other antifungal agentsG G Zhanel, J A Karlowsky, S A Zelenitsky, et al.
International Journal of Antimicrobial Agents|August 23, 2001
Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999J A Karlowsky, M E Jones, C Thornsberry, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1999
Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study GroupG G Zhanel, J A Karlowsky, L Palatnick, et al.
Pageof 8

Showing results (31-40 of 76) with videos related to

Sort By:
Pageof 8
Journal of Clinical Microbiology|July 17, 1998
Screening of stool samples for identification of vancomycin-resistant Enterococcus isolates should include the methyl-alpha-D-glucopyranoside test to differentiate nonmotile Enterococcus gallinarum from E. faeciumC Y Turenne, D J Hoban, J A Karlowsky, et al.
Diagnostic Microbiology and Infectious Disease|November 14, 1997
Candidemia in a Canadian tertiary care hospital from 1976 to 1996J A Karlowsky, G G Zhanel, K A Klym, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Influence of human serum on pharmacodynamic properties of an investigational glycopeptide, LY333328, and comparator agents against Staphylococcus aureusG G Zhanel, I D Kirkpatrick, D J Hoban, et al.
Antimicrobial Agents and Chemotherapy|May 1, 1993
In vitro postantibiotic effects following multiple exposures of cefotaxime, ciprofloxacin, and gentamicin against Escherichia coli in pooled human cerebrospinal fluid and Mueller-Hinton brothJ A Karlowsky, G G Zhanel, R J Davidson, et al.
Antimicrobial Agents and Chemotherapy|August 26, 2009
In vitro activity of colistin (polymyxin E) against 3,480 isolates of gram-negative bacilli obtained from patients in Canadian hospitals in the CANWARD study, 2007-2008A Walkty, M DeCorby, K Nichol, et al.
Antimicrobial Agents and Chemotherapy|June 1, 1996
In vitro characterization of aminoglycoside adaptive resistance in Pseudomonas aeruginosaJ A Karlowsky, M H Saunders, G A Harding, et al.
Diagnostic Microbiology and Infectious Disease|October 9, 2014
In vitro activity of oritavancin against Gram-positive pathogens isolated in Canadian hospital laboratories from 2011 to 2013J A Karlowsky, A J Walkty, M R Baxter, et al.
Antimicrobial Agents and Chemotherapy|September 16, 1998
Susceptibilities of Candida species isolated from the lower gastrointestinal tracts of high-risk patients to the new semisynthetic echinocandin LY303366 and other antifungal agentsG G Zhanel, J A Karlowsky, S A Zelenitsky, et al.
International Journal of Antimicrobial Agents|August 23, 2001
Prevalence of antimicrobial resistance among urinary tract pathogens isolated from female outpatients across the US in 1999J A Karlowsky, M E Jones, C Thornsberry, et al.
Antimicrobial Agents and Chemotherapy|October 3, 1999
Prevalence of antimicrobial resistance in respiratory tract isolates of Streptococcus pneumoniae: results of a Canadian national surveillance study. The Canadian Respiratory Infection Study GroupG G Zhanel, J A Karlowsky, L Palatnick, et al.
Pageof 8